MedicaidCoverageLow impact
Confirmation of Coverage for Karyotype and Hormone Related Testing to Diagnose Klinefelter Syndrome per Public Act 104-0073
Illinois Medicaid - HFS·IL · Endocrinology, Genetics, Urology +1 more·Provider Notice
Effective date
Jan 1, 2027
We identified it
Jun 20, 2026
Summary
Illinois Medicaid confirms existing coverage for karyotype and hormone testing to diagnose Klinefelter syndrome, as required by Public Act 104-0073. No billing changes are needed since coverage is already provided under fee-for-service and managed care programs.
Action Required
No action required. This is a confirmation notice that existing coverage for Klinefelter syndrome diagnostic testing will continue. Illinois Medicaid providers can continue billing for karyotype and hormone testing as currently practiced.